Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines

Cancer Detection and Prevention

Volumn 32, Issue 4, 2009, Pages 319-328

  Ifere, Godwin O ^a   Barr, Erika ^a   Equan, Anita ^a   Gordon, Kereen ^a   Singh, Udai P ^b   Chaudhary, Jaideep ^a   Igietseme, Joseph U ^c   Ananaba, Godwin A ^a  

^a CLARK ATLANTA UNIVERSITY   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; Biomarkers; Caveolin 1; Chemoprevention; Cholesterol; PCGEM1; Phytosterols; Prostate cancer; Proto oncogene; Sterols

Indexed keywords

CAMPESTEROL; CAVEOLIN 1; CHOLESTEROL; LIPOCORTIN 5; PHYTOSTEROL; PROPIDIUM IODIDE; SITOSTEROL; TRYPAN BLUE;

ANDROGEN INSENSITIVITY SYNDROME; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL STRAIN; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DISEASE MARKER; DNA FRAGMENTATION; DRUG CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MITOSIS INDEX; MITOSIS INHIBITION; NITROBLUE TETRAZOLIUM TEST; ONCOGENE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROL SYNTHESIS; UPREGULATION;

APOPTOSIS; CAVEOLIN 1; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHOLESTEROL; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PHYTOSTEROLS; PROSTATIC NEOPLASMS; RNA, UNTRANSLATED;

EID: 60749137355     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.12.002     Document Type: Article

References (40)

1. Platz E.A., Rimm E.B., Willett W.C., and Kantoff P.W. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst 92 (2000) 2009-20017.7
2. Hayes R.B. Are dietary fat vasectomy risk factors for prostate cancer?. J Natl Cancer Inst 87 (1995) 629-631
3. Awad A.B., and Fink C.S. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 130 (2000) 2127-2130
4. Von Holtz R.L., Fink C.S., and Awad A.B. β-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCap human prostate cancer cells. Nutr Cancer 32 (1998) 8-12
5. Arora A., Raghuraman H., and Chattopadhay A. Influence of cholesterol and ergosterol on membrane dynamics: a fluorescence approach. Biochem Biophys Res Commun 318 (2004) 920-926
6. Daniel E.E., El-Yazbi A., and Cho W.J. Caveolae and calcium handling, a review and a hypothesis. J Cell Mol Med 10 (2006) 529-544
7. Zhuang L., Kim J., Adam R.M., Solomon K.R., and Freeman M.R. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 115 (2005) 959-968
8. Williams T.M., and Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann Med 36 (2004) 584-595
9. Cohen A.W., Hnasko R., Schubert W., and Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol Rev 84 (2004) 1341-1379
10. Yang G., Truong L.D., Wheeler T.M., and Thompson T.C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 59 (1999) 5719-5723
11. Yang G., Addai J., Ittmann M., Wheeler T.M., and Thompson T.C. Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clin Cancer Res 6 (2000) 3430-3433
12. Li L., Yang G., Ebara S., Satoh T., Nasu Y., Timmen T.L., et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 61 (2001) 4386-4392
13. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275 (2000) 17221-17224
14. Razandi M., Alton G., Pedram A., Ghonshani S., Webb P., and Levin E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23 (2003) 1633-1646
15. Lu M.L., Schneider M.C., Zheng Y., Zhang X., and Richie J.P. Caveolin-1 interacts with androgen receptor, a positive modulator of androgen receptor mediated transactivation. J Biol Chem 276 (2001) 13442-13451
16. Bruggers C.S., Fults D., Perkins S.L., Coffin C.M., and Carroll W.L. Coexpression of genes involved in apoptosis in central nervous system neoplasms. Pediatr Hematol Oncol 21 (1999) 19-25
17. Bist A., Fielding C.J., and Fielding P.E. P53 regulates caveolin gene transcription, cell cholesterol and growth by a novel mechanism. Biochemistry 39 (2000) 1966-1972
18. Homma Y., Kondo Y., Kaneko M., Kitamura T., Nyou W.T., Yanagisawa M., et al. Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogenesis 25 (2004) 1011-1014
19. Chen K., Albano A., Ho A., and Keaney Jr. J.F. Activation of p53 by oxidative stress involves platelet-derived growth factor-β receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation. J Biol Chem 278 (2003) 39527-39533
20. Segawa T., Nau M.E., Xu L.L., Chilukuri R.N., Makarem M., Zhang W., et al. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21 (2002) 8749-8758
21. Petrovics G., Zhang W., Makarem M., Street J.P., Connely R., Sun L., et al. Elevated expression of PCGEM, a prostate-specific gene with cell growth-promoting function, is associated with high risk prostate cancer patients. Oncogene 23 (2004) 605-611
22. 2- terminal protein kinases in atherosclerotic lesions coincide with p53. Am J Pathol 156 (2000) 1875-1886
23. Awad A.B., Chan K.C., Downie A.C., and Fink C.S. Peanuts as a source of β-sitosterol, a sterol with anticancer properties. Nutr Cancer 36 (2000) 238-241
24. Awad A.B., Williams H., and Fink C.S. Effect of phytosterols on cholesterol metabolism and MAP kinase in MDA-MB-231 human breast cancer cells. J Nutr Biochem 14 (2003) 111-119
25. Greenberg-Ofrath N., Terespolosky Y., Kahane I., and Bar R. Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas. Appl Environ Microbiol 59 (1993) 547-551
26. Bishop O.N. Statistics for biology . Microcomputer (1985), Longman (EF) Ltd., London
27. 21-WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 98 (1996) 426-433
28. cdc2 kinase activity and arrest the cell cycle at G2. FASEB J 13 (1999) 1359-1370
29. Awad A.B., Fink C.S., Williams H., and Kim U. In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells. Eur J Cancer Prev 10 (2001) 507-513
30. Corban-Weilhelm H., Ehemann V., Becker G., Greulich D., Braun K., and Debus J. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther 11 (2004) 208-214
31. Srinkantan V., Zhiqiang Z., Petrovics G., Xu L., Augustus M., Davis L., et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA 97 (2000) 12216-12221
32. Goh M., Chen F., Paulsen M.T., Yeager A.M., Dyer E.S., and Ljungman M. Phenylbutyrate attenuates the expression of Bcl-XL, DNA-PK, Caveolin-1, and VEGF in prostate cancer cells. Neoplasia 3 (2001) 331-338
33. Fiucci G., Ravid D., Reich R., and Liscovitch M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21 (2002) 2365-2375
34. Williams T.M., Hassan G.S., Li J., Cohen A.W., Medina F., Frank P.G., et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 280 (2005) 25134-25145
35. Thompson C.T. Metastasis-related genes in prostate cancer: the role of caveolin-1. Cancer Metast Rev 17 (1999) 439-442
36. Freeman M.R., and Solomon K.R. Cholesterol and prostate cancer. J Cell Biochem 91 (2004) 54-69
37. Reddy S., Shapiro M., Morton R., and Brawley O.W. Prostate cancer in black and white Americans. Cancer Metast Rev 22 (2003) 83-86
38. Fu X., Ravindranath L., Tran N., Petrovics G., and Srivastava S. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol 25 (2006) 135-141
39. Banerjee P., Banerjee S., and Brown T.R. Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology 143 (2002) 1825-1832
40. Rusinol A.E., Thewke D., Liu J., Freeman N., Panini S.R., and Sinensky M.S. AKT/Protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 279 (2004) 1392-1399